AP3S1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.700200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.821000E-01
Normal-vs-Stage2
9.315000E-01
Normal-vs-Stage3
6.873200E-01
Normal-vs-Stage4
4.997200E-01
Stage1-vs-Stage2
2.283200E-01
Stage1-vs-Stage3
6.980600E-01
Stage1-vs-Stage4
8.043800E-02
Stage2-vs-Stage3
5.450600E-01
Stage2-vs-Stage4
6.177200E-01
Stage3-vs-Stage4
3.553600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.695400E-01
Normal-vs-AfricanAmerican
7.719400E-01
Normal-vs-Asian
8.366400E-01
Caucasian-vs-AfricanAmerican
6.575000E-01
Caucasian-vs-Asian
7.187400E-01
AfricanAmerican-vs-Asian
9.961600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.827600E-01
Normal-vs-Female
9.121000E-01
Male-vs-Female
6.392000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.447800E-02
Normal-vs-Age(41-60Yrs)
6.037800E-01
Normal-vs-Age(61-80Yrs)
7.961600E-01
Normal-vs-Age(81-100Yrs)
8.080000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.452500E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.172200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.338100E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.003300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.905170E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.572800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.105200E-01
Normal-vs-Daily Drinker
6.869800E-01
Normal-vs-Weekly Drinker
8.662600E-01
Normal-vs-Occasional Drinker
6.356000E-01
Normal-vs-Social Drinker
8.270400E-01
Non Drinker-vs-Daily Drinker
9.243600E-01
Non Drinker-vs-Weekly Drinker
7.552800E-01
Non Drinker-vs-Occasional Drinker
1.198580E-01
Non Drinker-vs-Social Drinker
2.696600E-01
Daily Drinker-vs-Weekly Drinker
7.156200E-01
Daily Drinker-vs-Occasional Drinker
1.176620E-01
Daily Drinker-vs-Social Drinker
2.733000E-01
Weekly Drinker-vs-Occasional Drinker
2.640200E-01
Weekly Drinker-vs-Social Drinker
5.301800E-01
Occasional Drinker-vs-Social Drinker
5.419000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.150400E-01
Normal-vs-Grade 2
8.250800E-01
Normal-vs-Grade 3
8.122800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.22650000003544E-06
Grade 1-vs-Grade 3
1.039330E-04
Grade 1-vs-Grade 4
9.150400E-01
Grade 2-vs-Grade 3
7.811200E-01
Grade 2-vs-Grade 4
8.250800E-01
Grade 3-vs-Grade 4
8.122800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.197200E-01
Normal-vs-NonDiabetic
9.759200E-01
Diabetic-vs-NonDiabetic
8.352800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.920600E-01
Normal-vs-NoPancreatitis
9.856600E-01
Pancreatitis-vs-NoPancreatitis
4.058800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.854800E-01
Normal-vs-N1
9.646600E-01
N0-vs-N1
2.602800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.392000E-01
Normal-vs-TP53-NonMutant
5.309000E-01
TP53-Mutant-vs-TP53-NonMutant
3.812600E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
